angiotensin ii has been researched along with Aortic Valve Disease 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiminazzo, V; Del Río-García, Á; López-Larrea, C; Martín, M; Mohamedi, Y; Rodrigues-Díez, RR; Rodríguez, I; Ruiz-Ortega, M; Suárez-Álvarez, B; Tejera-Muñoz, A | 1 |
| Casaclang-Verzosa, G; Hagler, MA; Miller, JD; Nair, AA; Suri, RM; Thalji, NM; Zhang, H | 1 |
2 other study(ies) available for angiotensin ii and Aortic Valve Disease 1
| Article | Year |
|---|---|
The CCN2 Polymorphism rs12526196 Is a Risk Factor for Ascending Thoracic Aortic Aneurysm.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Thoracic; Bicuspid Aortic Valve Disease; Humans; Mice; Retrospective Studies; Risk Factors | 2022 |
Nonbiased Molecular Screening Identifies Novel Molecular Regulators of Fibrogenic and Proliferative Signaling in Myxomatous Mitral Valve Disease.
Topics: Angiotensin II; Animals; Aortic Valve; beta Catenin; Bicuspid Aortic Valve Disease; Bone Morphogenetic Protein 4; Cells, Cultured; Cytokines; Echocardiography; Gene Expression Regulation; Heart Defects, Congenital; Heart Valve Diseases; Humans; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mitral Valve; Real-Time Polymerase Chain Reaction; Signal Transduction; Transforming Growth Factor beta2; Wnt Proteins | 2015 |